Can gene-modified stem cells outsmart HIV and beat lymphoma?

NCT ID NCT02797470

First seen Jun 03, 2026 · Last updated Jun 15, 2026 · Updated 3 times

Summary

This early-phase study tests a gene therapy for people with HIV who also have lymphoma that didn't respond to treatment or came back. Doctors take the patient's own stem cells, add special anti-HIV genes in the lab, and give them back after a stem cell transplant. The goal is to see if this approach is safe and can make immune cells resistant to HIV, helping control both the virus and the cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT FOLLICULAR LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • UC San Diego Moores Cancer Center

    La Jolla, California, 92093, United States

  • UCSF Medical Center-Parnassus

    San Francisco, California, 94115, United States

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California, 95817, United States

Conditions

Explore the condition pages connected to this study.

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.